Review explores the HO/CO pathway's role in thermoregulation and neuroenergetics during stress, suggesting therapeutic approaches.
This review explores the heme oxygenase/carbon monoxide (HO/CO) pathway as a central integrator of thermoregulation and neuroenergetics during inflammatory and oxidative stress. Thermoregulation is framed not merely as a homeostatic process, but as a continuous problem of energy allocation where body temperature (Tb) serves as an indicator of an organism's bioenergetic capacity. The core mechanistic thesis identifies the HO/CO system as a state-dependent "coupling pathway" that links inflammatory and redox tone to mitochondrial performance and, through central autonomic hierarchies, to the selection of thermal phenotypes, such as fever, regulated hypothermia, or torpor-like states. While fever supports "resistance" at a high metabolic cost, regulated hypothermia aligns with "tolerance" by conserving energy when resources or oxygen delivery are constrained. Key knowledge gaps remain regarding the precise cell-type-specific roles of HO-1 in the central nervous system (CNS) and the context-dependent nature of CO signaling via soluble guanylyl cyclase (sGC) in vivo. Therapeutically, targeting the HO/CO pathway via inhaled CO, CO-releasing molecules (CORMs), or HO-1 induction offers prospects for modulating neuroinflammation and metabolic resilience. However, translational constraints include timing-dependent effects and the need for precision phenotyping to identify which patients might benefit from interventions. In conclusion, the HO/CO system is discussed as a sophisticated modulator that biases thermoregulatory strategy based on the immediate physiological constraints of oxygen delivery and energetic reserve.
No takes yet. Share an insight, caveat, or question.
Cárnio et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: